| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |